scenario : you can design health promotion programs for ex-military service persons. You are interested to know more abo

[answerhappygod]

scenario :
you can design health promotion programs for ex-military
service persons. You are interested to know more about
interventions for post-traumatic stress disorder. Recently there
have been changes to the availability of cannabis in NSW. Find the
best available evidence to inform you as to whether medicinal
cannabis is effective in reducing mental health symptoms in this
group.
Evidence Question (below please correct )
Is medicinal cannabis effective in reducing veterans mental
health symptoms in post-traumatic stress disordered patients,
compared to no treatment options?
PICO
Traditional medicine, conventional medicine, mainstream
Control , no treatment.
Evidence 1
Journal title: ve Medicinal rsus recreational cannabis
use: Patterns of cannabis use, alcoh...: EBSCOhost (uws.edu.au)
Level one
A systematic Review
100% relevant
This systematic review was chosen because of its high quality ,
it collates multiple studies which provided a comprehenslve summary
of all the relevant PICO questions. the velerans as the
primary population group. present data ,it is also comparatively
recent with a focus on veterans highlighting its relevance, the
study with ex-military persons with psychosocial issues and how
cannabis use affected them. further more its use in a control group
to dismiss placebo
: Evidence justification . (please fix
and current)
justify the article (Evidence 1) as best available
evidence that contributes to answering the evidence
question.
The age of the article is fairly new, which increases its
validity (published 2019). The question in the study is very
similar to the evidence question that was created; therefore, it is
highly relevant. It is a systematic review, summarising and
evaluating findings from several research articles. The study
ensured that they chose the right sample of people, which included
veterans that use cannabis for medicinal or other reasons in aims
to combat the trauma. Assessment measures were administered through
a large amount of testing methods that are highly effective. For
example, a series of Bonferroni corrected one-way analyses of
variance, t-tests, bivariate and partial correlations, and a
Chi-square test. Using Boolean operators and advanced searching on
CINAHL, also covered PICO framework.
attached the article
Abstract:
Use of Medicinal Cannabis and Synthetic Cannabinoids in
Post-Traumatic Stress Disorder (PTSD): A Systematic
Review
Laura Orsolini 1 2 3, Stefania Chiappini 4, Umberto
Volpe 5, Domenico De Berardis 6 7 8, Roberto Latini 9, Gabriele
Duccio Papanti 4, And John Martin Corkery 4
Affiliations expand
PMID: 31450833 PMCID: PMC6780141 DOI:
10.3390/medicina55090525
Free PMC article
Abstract
Background and objectives: Post-traumatic stress
disorder (PTSD) is a common psychiatric disorder resulting from a
traumatic event, is manifested through hyperarousal, anxiety,
depressive symptoms, and sleep disturbances. Despite several
therapeutic approaches being available, both pharmacological and
psychological, recently a growing interest has developed in using
cannabis and synthetic cannabinoids stems from their consideration
as more efficient and better tolerated alternatives for the
treatment of this condition. The present paper aims to evaluate the
clinical and therapeutic potentials of medical cannabis and
synthetic cannabinoids in treating PTSD patients.
Methods: A systematic electronic search was performed,
including all papers published up to May 2019, using the following
keywords (((cannabis[Title/Abstract]) OR (synthetic cannabinoids
[Title/Abstract])) AND ((PTSD[Title/Abstract]) OR (Posttraumatic
stress disorder[Title/Abstract]))) for the topics 'Cannabis',
'Synthetic Cannabinoids', 'PTSD', and MESH terms, on the PubMed,
Cochrane Library, and Web of Science online databases. For data
gathering purposes, PRISMA guidelines were followed. Results were
organized into two groups, considering cannabis and synthetic
cannabinoids a
Use of Medicinal Cannabis and Synthetic Cannabinoids in
Post-Traumatic Stress Disorder (PTSD): A Systematic
Review
Laura Orsolini 1 2 3, Stefania Chiappini 4, Umberto
Volpe 5, Domenico De Berardis 6 7 8, Roberto Latini 9, Gabriele
Duccio Papanti 4, And John Martin Corkery 4
Affiliations expand
PMID: 31450833 PMCID: PMC6780141 DOI:
10.3390/medicina55090525
Free PMC article
Abstract:
Use of Medicinal Cannabis and Synthetic Cannabinoids in
Post-Traumatic Stress Disorder (PTSD): A Systematic
Review
Laura Orsolini 1 2 3, Stefania
Chiappini 4, Umberto
Volpe 5, Domenico De
Berardis 6 7 8, Roberto
Latini 9, Gabriele Duccio
Papanti 4, And John Martin
Corkery 4
Affiliations expand
Free PMC article
Abstract
Background and objectives: Post-traumatic
stress disorder (PTSD) is a common psychiatric disorder resulting
from a traumatic event, is manifested through hyperarousal,
anxiety, depressive symptoms, and sleep disturbances. Despite
several therapeutic approaches being available, both
pharmacological and psychological, recently a growing interest has
developed in using cannabis and synthetic cannabinoids stems from
their consideration as more efficient and better tolerated
alternatives for the treatment of this condition. The present paper
aims to evaluate the clinical and therapeutic potentials of medical
cannabis and synthetic cannabinoids in treating PTSD patients.
Methods: A systematic electronic search
was performed, including all papers published up to May 2019, using
the following keywords (((cannabis[Title/Abstract]) OR (synthetic
cannabinoids [Title/Abstract])) AND ((PTSD[Title/Abstract]) OR
(Posttraumatic stress disorder[Title/Abstract]))) for the topics
'Cannabis', 'Synthetic Cannabinoids', 'PTSD', and MESH terms, on
the PubMed, Cochrane Library, and Web of Science online databases.
For data gathering purposes, PRISMA guidelines were followed.
Results were organized into two groups, considering cannabis and
synthetic cannabinoids as different therapeutic approaches for
PTSD.
Results: Present data show that cannabis
and synthetic cannabinoids, both acting on the endocannabinoids
system, may have a potential therapeutic use for improving PTSD
symptoms, e.g., reducing anxiety, modulating memory-related
processes, and improving sleep.
Conclusions: Even though the current
literature suggests that cannabis and synthetic cannabinoids may
have a role in the treatment of PTSD, there is currently limited
evidence regarding their safety and efficacy. Therefore, additional
research is needed in order to better understand the effectiveness
and therapeutic usage of these drug classes and monitor their
safety.
Keywords: CBD; PTSD; cannabinoids;
cannabis; endocannabinoid system; synthetic cannabinoids;
trauma.
Conflict of interest statement
The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.